Kaplan–Meier survival analysis of TCGA-COAD datasets revealed a significantly poorer 5-year overall survival rate in patients with CRC with a high FOXS1 expression than in patients with a low FOXS1 expression (Figure 1D). This evidence concerns the gene FOXS1 and colorectal carcinoma.